Cryoport, Inc. operates through two primary segments: Life Sciences Services and Life Sciences Products. The Services segment offers temperature-controlled logistics, biostorage, and bioservices, including kit production and secondary packaging for clinical trials and commercial therapies. The Products segment manufactures cryogenic storage and transportation systems through its MVE Biological Solutions subsidiary. The company maintains a global footprint across the Americas, EMEA, and APAC regions, supporting hundreds of clinical trials and numerous commercial cell and gene therapies. Cryoport's platform is designed to manage the transport and storage of temperature-sensitive biological materials, reproductive medicine samples, and animal health products.
